July 2013
Synthesis and Characterization of Bis-quinazolines from Linear Tetraamines
Involving 2-(Aminomethyl)benzenamine with Aldehydes
981
MHz, DMSO‐d6, ppm): 2.74 and 2.94 (4H, CH2 N), 3.74 (s, 10H,
CH2 benzyl and OCH3), 5.27 and 5.32 (s, 2H, methine), 6.51–7.01
(m, 14H, Ar), 10.29 (br, 2H, OH). 13C NMR δC (300 MHz, DMSO‐
d6, ppm): 48.20, 48.42, 49.54, 50.01, 56.02, 56.05, 68.86, 69.19,
112.36, 114.09, 116.62, 116.78, 118.59, 120.25, 127.38, 127.68,
142.49, 142.72, 145.43, 147.93, 147.99. Anal. Calcd for
C32H34N4O4: C, 71.35; H, 6.36; N, 10.40. Found: C, 71.40; H, 6.32;
N, 10.42.
2‐(2‐Nitrophenyl)‐3‐(2‐(2‐(2‐nitrophenyl)‐1,2‐dihydroquinazolin‐
3(4H)‐yl)ethyl)‐1,2,3,4‐tetrahydroquinazoline (2). Yield: (75%), IR
(KBr, cm−1): 3421 s (NH), 1361 and 1520 (NO2). 1H NMR δH (300
MHz, CDCl3, ppm): 2.67 (4H, CH2 N), 3.32 (d, 4H, CH2 benzyl),
4.61(br, 2H, NH), 5.87 (s, 2H, methine), 6.41–7.71 (m, 16H, Ar).
13C NMR δC (300 MHz, DMSO‐d6, ppm): 46.31, 50.73, 68.87,
114.16, 117.63, 124.49, 127.76, 128.25, 129.44, 129.53, 132.22,
137.04, 142.28, 149.23. Anal. Calcd for C30H28N6O4: C, 67.15; H,
5.26; N, 15.66. Found: C, 67.15; H, 5.23; N, 15.71.
2‐(3‐(4‐(2‐(2‐Hydroxyphenyl)‐1,2‐dihydroquinazolin‐3(4H)‐
yl)butyl)‐1,2,3,4‐tetrahydroquinazolin‐2‐yl)phenol (7). Yield:
1
(80%), IR (KBr, cm−1): 3423 s (NH). H NMR δH (300 MHz,
DMSO‐d6, ppm): 1.61 (4H, C‐CH2 CH2 C), 2.49 and 2.72 (4H,
CH2 N), 3.20 (NH ), 3.54 and 3.72(d, 4H, CH2 benzyl), 5.21 (s,
2H, methine) 6.22–7.27 (m, 16H, Ar), 11.09 (s, 2H, OH). 13C
NMR δC (300 MHz, DMSO‐d6, ppm): 25.32, 47.08,
47.20,51.12, 69.68, 69.79, 114.29, 116.27, 116.31, 116.35,
117.02, 119.11, 126.57, 127.78, 128.44, 129.42, 142.20,
156.61. Anal. Calcd for C32H34N4O2: C, 75.86; H, 6.76; N,
11.06. Found: C, 75.86; H, 6.76; N, 11.06.
Acknowledgments. The authors are thankful to Payame Noor
University (PNU) for financial support.
2‐(3‐(3‐(2‐(2‐Hydroxy‐3‐methoxyphenyl)‐1,2‐dihydroquinazolin‐
3(4H)‐yl)propyl)‐1,2,3,4‐tetrahydroquinazolin‐2‐yl)‐6‐methoxyphenol
REFERENCES AND NOTES
1
(3). Yield: (75%), IR (KBr, cm−1): 3409 s (NH). H NMR δH
[1] Mark, S.; Jan, E.; Sabrina, A.; Martina, L.; Silke, A.; Yeon, R.;
Jodi, A.; Gillian, S.; William, R.; Detlef, M.; Stephen, E.; Bert, K.;
Thomas, S.; Manfred, M. Antivir Res 2008, 79, 49.
[2] Kubicova, L.; Kudelova, P.; Dostal, H.; Waisser, K. Folia
Pharm Univ Carol 2000, 25, 81.
(300 MHz, CDCl3, ppm): 1.86 (2H, C CH2 C), 2.71 (4H,
CH2 N), 3.84 (s, 10H, CH2 benzyl and OCH3),4.51(br, 2H,
NH), 5.17 (s, 2H, methine) 6.41–7.21 (m, 14H, Ar). 13C NMR
δC (300 MHz, DMSO‐d6, ppm): 25.37, 46.81, 47.17, 49.17,
56.05, 69.31, 69.71, 112.46, 114.09, 116.28, 116.90, 118.56,
120.22, 127.20, 127.76, 142.28, 145.61, 147.92. Anal. Calcd
for C33H36N4O4: C, 71.72; H, 6.57; N, 10.14. Found: C, 71.81;
H, 6.62; N, 10.13.
[3] Hanusek, J. Chem Listy 2001, 95, 811.
[4] Chan, H. J.; Hong, J. S.; Kuyper, L. F.; Baccanari, D. P.;
Joyner, S. S.; Tansik, R. L.; Boytos, C. M.; Rudolph, S. K. J Med Chem
1995, 38, 3608.
[5] Castaldo, R.; Gump, D.; Cormack, Mc.;Antimicrob. J. Agents
Chemother 1979, 15, 81.
[6] Harushia, K.; Kiesuke, Y.; Seiko, H.; Shingo, H.; Ryota, K.;
Norimitsu, H.; Makoto, M.; Yoshiteru, O. J Med Chem 2006, 49, 4698.
[7] Yasutaka, T.; Takao, S.; Nobuhisa, W.; Hideyuki, A.; Shigeru,
S.; Isao, S. J Med Chem 1994, 37, 2106.
[8] Marianne, D.; Fredric, P.; Olivier, C.; Jean‐Claude, T.; Jean‐
Pierre, C.; Yves, B. Chem Pharm Bull 2001, 49, 1061.
[9] Mani Chandrica, P.; Yakaiah, T.; Raghu Ram Rao, A.;
Narsaiah, B.; ChakraReddy, N.; Sridhar, V.; Venkateshwara Rao, J. Eur
J Med Chem 2008, 43, 846.
2‐(2‐Nitrophenyl)‐3‐(3‐(2‐(2‐nitrophenyl)‐1,2‐dihydroquinazolin‐
3(4H)‐yl)propyl)‐1,2,3,4‐tetrahydroquinazoline (4). Yield: (77%), IR
1
(KBr, cm−1): 3422 s (NH). H NMR δH (300 MHz, CDCl3, ppm):
1.61 (2H, C CH2 C), 2.51 (4H, CH2 N), 3.47 (s, 4H, CH2 benzyl),
4.52(br, 2H, NH), 5.76 (s, 2H, methine) 6.39–7.63 (m, 14H, Ar) 13C
NMR δC (300 MHz, CDCl3, ppm): 25.43, 45.82, 50.23, 114.04,
117.68, 124.41, 127.53, 128.24, 129.33, 129.60, 131.67, 134.22,
137.06, 141.28, 148.92. Anal. Calcd for C31H30N6O4: C, 67.62; H,
5.49; N, 15.26. Found: C, 67.60; H, 5.43; N, 15.20.
[10] Yen, M. H.; Sheu, J. R.; Peng, I. H.; Lee, Y. M.; Chern, J. W. J
Pharm Pharmacol 1996, 48, 90.
[11] Hyao, S.; Mvera, M. J.; Strycker, W.; Leipzi, T.; Klup, R.;
Hartzler, H. J Med Chem 1965, 8, 807.
2‐(3‐(4‐(2‐(2‐Hydroxy‐3‐methoxyphenyl)‐1,2‐dihydroquinazolin‐
3(4H)‐yl)butyl)‐1,2,3,4‐tetrahydroquinazolin‐2‐yl)‐6‐methoxyphenol
1
(5). Yield: (80%), IR (KBr, cm−1): 3404 s (NH). H NMR δH (300
MHz, DMSO‐d6, ppm): 1.69 (4H, C CH2 CH2 C), 2.75 (4H,
CH2 N), 3.82 (s, 10H, CH2 benzyl and OCH3), 4.49 (br, 2H, NH),
5.21 (s, 2H, methine) 6.54–7.16 (m, 14H, Ar). 13C NMR δC (300
MHz, DMSO‐d6, ppm): 25.28, 47.16, 51.16, 56.07, 112.55, 114.17,
116.28, 116.96, 118.56, 120.23, 127.08, 127.79, 142.27, 145.78,
147.97. Anal. Calcd for C34H38N4O4: C, 72.06; H, 6.76; N, 9.89.
Found: C, 72.11; H, 6.77; N, 9.89.
[12] Cohen, E.; Klarberg, E.;JamesVaughan R., Jr. J Am Chem Soc
1960, 82, 2731.
[13] Sielecki, T. M.; Johnson, T. L.; Liu, J.; Muckelbauer, J. K.;
Grafstrom, R. H.; Cox, S.; Boylan, J.; Burton, C. R.; Chen, H.;
Smallwood, A.; Chang, C.; Boisclair, M.; Benfield, P. A.; Trainor, G.
L.; Seitz, S. P. Bioorg Med Chem Lett 2001, 11, 1157.
[14] ArchanaSrivastava, V. K.; Ramesh, C.; Ashok, K. Indian J
Chem 2002, 41B, 2371.
[15] Joachim, R.; William, P. E.; Stephen, O.; Philip, D. G. C.;
Philip, L. W.; Michael, B.; Donald, E. B.; Brian, T. B.; Georgiy, B.;
Libing, C.; Chih‐Yuan, C.; Thomas, H. C.; Zahra, F.; Wenlang, F.; Uday,
R. K.; James, A. K.; Xiao‐Gao, L.; Derek, B. L.; Andrea, C. M.; Martin,
M.; Astrid, A. O.; Philip, D. R.; Robert, W. S.; Tatiana, E. S.; Alexandros,
V.; Weifeng, T.; Lei, W.; Lin, Y.; Stephen, J. G.; James, N. L.; Laurel, J.
S.; William, H. B. J Med Chem 2007, 50, 5202.
2‐(2‐Nitrophenyl)‐3‐(4‐(2‐(2‐nitrophenyl)‐1,2‐dihydroquinazolin‐
3(4H)‐yl)butyl)‐1,2,3,4‐tetrahydroquinazoline (6). Yield: (81%), IR
1
(KBr, cm−1): 3423 s (NH). H NMR δH (300 MHz, CDCl3, ppm):
1.44 (4H, C CH2 CH2 C), 2.49 (4H, CH2 N), 3.38 (s, 4H, CH2
benzyl), 4.53 (br, 2H, NH), 5.83 (s, 2H, methine), 6.54–7.8 (m, 16H,
Ar) 13C NMR δC (300 MHz, DMSO‐d6, ppm): 25.04, 45.89, 52.16,
52.53, 68.32, 113.70, 116.69, 117.17, 124.85, 127.75, 127.82,
129.14, 129.33, 132.22, 136.97, 142.27, 149.15. Anal. Calcd for
C32H32N6O4: C, 68.07; H, 5.71; N, 14.88. Found: C, 68.02; H, 5.74;
N, 14.92.
[16] Atsuo, B.; Noriaki, K.; Haruhiko, M.; Yoshikazu, O.;
Shigehisa, T.; Takashi, S. J Med Chem 1996, 39, 5176.
[17] Daniel, B. Y.; Jason, W. G.; Stephanie, L. N.; Arely, V. P.;
Matthew, T. C.; David, A. B. J Dermatol Sci 2006, 42, 13.
Journal of Heterocyclic Chemistry
DOI 10.1002/jhet